Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP520188.RAjfS7-S6hl9fqW8Fd6wZYc76kRjva4VjS9F-fpQVtims130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP520188.RAjfS7-S6hl9fqW8Fd6wZYc76kRjva4VjS9F-fpQVtims130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP520188.RAjfS7-S6hl9fqW8Fd6wZYc76kRjva4VjS9F-fpQVtims130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP520188.RAjfS7-S6hl9fqW8Fd6wZYc76kRjva4VjS9F-fpQVtims130_provenance.
- NP520188.RAjfS7-S6hl9fqW8Fd6wZYc76kRjva4VjS9F-fpQVtims130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP520188.RAjfS7-S6hl9fqW8Fd6wZYc76kRjva4VjS9F-fpQVtims130_provenance.
- NP520188.RAjfS7-S6hl9fqW8Fd6wZYc76kRjva4VjS9F-fpQVtims130_assertion evidence source_evidence_literature NP520188.RAjfS7-S6hl9fqW8Fd6wZYc76kRjva4VjS9F-fpQVtims130_provenance.
- NP520188.RAjfS7-S6hl9fqW8Fd6wZYc76kRjva4VjS9F-fpQVtims130_assertion SIO_000772 10071278 NP520188.RAjfS7-S6hl9fqW8Fd6wZYc76kRjva4VjS9F-fpQVtims130_provenance.
- NP520188.RAjfS7-S6hl9fqW8Fd6wZYc76kRjva4VjS9F-fpQVtims130_assertion wasDerivedFrom befree-20140225 NP520188.RAjfS7-S6hl9fqW8Fd6wZYc76kRjva4VjS9F-fpQVtims130_provenance.
- NP520188.RAjfS7-S6hl9fqW8Fd6wZYc76kRjva4VjS9F-fpQVtims130_assertion wasGeneratedBy ECO_0000203 NP520188.RAjfS7-S6hl9fqW8Fd6wZYc76kRjva4VjS9F-fpQVtims130_provenance.
- befree-20140225 importedOn "2014-02-25" NP520188.RAjfS7-S6hl9fqW8Fd6wZYc76kRjva4VjS9F-fpQVtims130_provenance.